Shionogi & Co. Ltd.

In News

Shionogi pays $2B to acquire a rare disease startup - BioPharma Dive

BioPharma Dive - Oct 05, 2026

Shionogi & Co., Ltd. (4507.T) stock price, news, quote and history - Yahoo Finance UK

Yahoo Finance UK - Oct 15, 2026

Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc. - BioSpace

BioSpace - Oct 05, 2026

Shionogi strikes $2B deal for IntraBio hot off FDA label expansion - Fierce Pharma

Fierce Pharma - Oct 05, 2026

Shionogi to Acquire IntraBio for $2 Billion - WSJ

WSJ - Oct 05, 2026

Japan’s Shionogi acquires America’s IntraBio in USD2bn deal - Law.asia

Law.asia - Oct 13, 2026

Shionogi to pay $2B for IntraBio, a commercial rare disease biotech - Endpoints News

Endpoints News - Oct 05, 2026

Shionogi Bets $2 Billion on IntraBio as Rare Disease Consolidation Heats Up - BigGo Finance

BigGo Finance - Oct 15, 2026

Shionogi Adds to Its Rare Disease Strategy With $2B IntraBio Acquisition - MedCity News

MedCity News - Oct 05, 2026

Shionogi bolsters rare disease portfolio with $2bn IntraBio buy - BioXconomy

BioXconomy - Oct 07, 2026

Shionogi Grows Rare Disease Portfolio with $2B IntraBio Acquisition - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Oct 06, 2026

Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech - Pharmaceutical Executive

Pharmaceutical Executive - Oct 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment